Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Actinium Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Actinium Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Actinium Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Actinium Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Actinium Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Actinium Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Actinium Pharma Raises US$5 Million In First Closing Of Venture Financing Round 11
Partnerships 12
Actinium Pharma Enters into Research and Option Agreement with Astellas Pharma 12
Actinium Pharma Partners with Vector Oncology 13
Actinium Pharma Enters into Agreement with Medpace 14
Actinium Pharma Enters into Co-Development Agreement with Albert Einstein College of Medicine 15
Licensing Agreements 16
Actinium Pharma Enters Into Licensing Agreement With Fred Hutchinson Cancer Research Center For BC8 16
Equity Offering 18
Actinium Pharma Prices Rights Offering of Units for USD25 Million 18
Actinium Pharma Raises USD16.1 Million in Public Offering of Shares and Warrants 20
Actinium Pharma Raises USD10 Million in Public Offering of Shares 22
Actinium Pharma Raises USD5 Million in Private Placement of Shares 24
Actinium Pharma Raises USD20 Million in Public Offering of Shares and warrants 26
Actinium Pharma Raises USD13.7 Million in Public Offering of Shares 28
Actinium Pharma Completes Second Tranche Of Private Placement Of Securities For US$3.3 Million 30
Actinium Pharma Completes Private Placement Of Shares For US$3.5 Million Upon Exercise Of Warrants 31
Actinium Pharma Plans IPO 32
Acquisition 33
Cactus Ventures Completes Acquisition Of Actinium Pharma In Reverse Takeover Transaction 33
Actinium Pharmaceuticals Inc – Key Competitors 34
Actinium Pharmaceuticals Inc – Key Employees 35
Actinium Pharmaceuticals Inc – Locations And Subsidiaries 36
Head Office 36
Recent Developments 37
Corporate Communications 37
May 01, 2018: Actinium Pharmaceuticals Appoints Dr. Jeffrey Chell, Bone Marrow Transplant Visionary and Chief Executive Officer Emeritus of Be The Match and National Marrow Donor Program, to its Board of Directors 37
Feb 08, 2018: Actinium Appoints Anil Kapur as Chief Commercial Officer to Build Critical Commercial & Launch Capabilities Focused on Myeloablation 38
Jan 08, 2018: Actinium Pharmaceuticals Appoints Dr. Dale L. Ludwig, Ph.D. as Chief Scientific Officer to Lead Efforts Focused on the Company’s AWE Technology Platform and Research Programs 39
Jun 09, 2017: Actinium Pharmaceuticals Announces Appointment of Sandesh Seth as Chief Executive Officer 40
Mar 28, 2017: Actinium Pharmaceuticals Appoints Pharmaceutical Industry Executive Ajit S. Shetty, Ph.D., to the Company’s Board of Directors 41
Jan 18, 2017: Actinium Strengthens Executive Team and Enhances Clinical Development Capabilities with the Appointment of Dr. Mark Berger as Chief Medical Officer 42
Product News 44
12/11/2017: Actinium Pharmaceuticals Highlights Data at the American Society of Hematology Annual Meeting Showing CD33 Expression in a Significant Number of Multiple Myeloma Patients Supporting the Rationale for Actimab-M 44
Nov 14, 2017: Actinium Pharmaceuticals Launches the AWE Program aka Actinium Warhead Enabling Program to Enable Collaborations Based on Its Actinium-225 Technology Platform 45
Oct 01, 2018: Actinium launches Iomab-ACT program offering its targeted chemo-free lymphodepletion technology as a universal solution to CAR-T product developers 47
Clinical Trials 48
Sep 13, 2017: Actinium Pharmaceuticals Highlights on Actimab-M at the Society of Hematologic Oncology 2017 Annual Meeting 48
Feb 13, 2017: Actinium Pharmaceuticals’ Company Presentation at BIO CEO & Investor Conference to Provide Highlights of Recently Announced Actimab-M Trial in Multiple Myeloma 49
Feb 07, 2017: Actinium Pharmaceuticals Announces Pipeline Expansion with Initiation of Clinical Trial of Actimab-M in Multiple Myeloma 50
Other Significant Developments 51
Jan 25, 2018: Actinium Pharmaceuticals Issues Letter to Investors Providing Company Update and Outlook for 2018 51
Appendix 53
Methodology 53
About GlobalData 53
Contact Us 53
Disclaimer 53
Actinium Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Actinium Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Actinium Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Actinium Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Actinium Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Actinium Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Actinium Pharma Raises US$5 Million In First Closing Of Venture Financing Round 11
Actinium Pharma Enters into Research and Option Agreement with Astellas Pharma 12
Actinium Pharma Partners with Vector Oncology 13
Actinium Pharma Enters into Agreement with Medpace 14
Actinium Pharma Enters into Co-Development Agreement with Albert Einstein College of Medicine 15
Actinium Pharma Enters Into Licensing Agreement With Fred Hutchinson Cancer Research Center For BC8 16
Actinium Pharma Prices Rights Offering of Units for USD25 Million 18
Actinium Pharma Raises USD16.1 Million in Public Offering of Shares and Warrants 20
Actinium Pharma Raises USD10 Million in Public Offering of Shares 22
Actinium Pharma Raises USD5 Million in Private Placement of Shares 24
Actinium Pharma Raises USD20 Million in Public Offering of Shares and warrants 26
Actinium Pharma Raises USD13.7 Million in Public Offering of Shares 28
Actinium Pharma Completes Second Tranche Of Private Placement Of Securities For US$3.3 Million 30
Actinium Pharma Completes Private Placement Of Shares For US$3.5 Million Upon Exercise Of Warrants 31
Actinium Pharma Plans IPO 32
Cactus Ventures Completes Acquisition Of Actinium Pharma In Reverse Takeover Transaction 33
Actinium Pharmaceuticals Inc, Key Competitors 34
Actinium Pharmaceuticals Inc, Key Employees 35
List of Figures
Actinium Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Actinium Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Actinium Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Actinium Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Actinium Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Actinium Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Actinium Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Actinium Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9